You are here: Industry Insights > Development

News List

Seven Proposed Cancellations of Health Food Functions! A Brief Discussion on the Development of Health Foods Xiaomichong
July 02, 2024
On January 13, the State Administration for Market Regulation issued a public consultation on the "Announcement on the Release of the Directory of Health Functions Allowed for Health Food Claims for Non-Nutrient Supplements and Supporting Documents".
What's happening in HF therapies Neeta Ratanghayra
January 02, 2024
Heart failure (HF) is a leading cause of disability worldwide and has a major impact on the global economy and healthcare systems.The severity of the disease warrants the development of innovative solutions to address the current treatment gap.
Global R&D Drug Development 2023: Overcoming Barriers, Bringing Hope to Patients and ESG focused Shruti Talashi
January 02, 2024
As the global healthcare system refocuses after the pandemic, a recent report on the global R&D trend 2023 which was put together as a public service by the IQVIA Institute for Human Data Science.
ProBioGen’s Growth Strategy Continues Successfully PharmaSources
March 06, 2023
In line with this growth, three crucial positions have been filled. These appointments reflect the company's commitment to continued growth.
Cidara and Mundipharma sign rezafungin drug development deal pharmaceutical-technology
September 05, 2019
US-based biotech Cidara Therapeutics has partnered with UK-based Mundipharma in a deal valued at more than $568m to develop and commercialise its anti-fungal drug rezafungin.
Provention Bio Appoints Clinical Development SVP contractpharma
August 21, 2019
Dr. Kell will lead the PRV-031 program, including the oversight of the Phase III PROTECT study and support of regulatory submissions.
Boehringer Ingelheim, MD Anderson Form Virtual Cancer R&D Center contractpharma
August 13, 2019
New potential gastrointestinal and lung cancer therapies from Boehringer’s pipeline will be combined with MD’s drug development capabilities.
Oric closes funding to develop glucocorticoid antagonist ORIC-101 pharmaceutical-technology
August 12, 2019
Oric Pharmaceuticals has closed a Series D financing to support the continued development of a clinical-stage, selective and potent glucocorticoid receptor antagonist, ORIC-101.
Sensyne Health and Bayer partner on AI drug development pharmaceutical-technology
August 05, 2019
Sensyne Health, a UK-based clinical artificial intelligence (AI) technology firm, has collaborated with German pharmaceutical company Bayer to accelerate the development of new heart therapies.
MilliporeSigma Launches Plug & Play Upstream Development Service contractpharma
August 02, 2019
Adaptive approach to cell line development, analytics and clone selection for emerging biotechs and start-ups.

Previous page 1 2 3 4 5 6 7 Next page